The study’s conclusions implied that mutations in genes encoding proteins of the CRBN-IKZF-IRF4 pathway may eventually elucidate the occurrence of IMiD resistance in more MM individuals than previously thought [50]. This evidence concerns the gene CRBN and Miyoshi myopathy.